02380 408 600 Contact us
Menu
×

Publications

  • Publication Subject

  • Filter by Author

The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.

  • Author

    Beverley R Twaites Lynda V Wilton Saad A W Shakir

    Beverley Twaites, Lynda Wilton, Saad Shakir

  • Cite

    J Psychopharmacol. 2007 Jun;21(4):392-9

View Publication

An analysis of the exclusion criteria used in observational pharmacoepidemiological studies

  • Author

    Michael Perrio Patrick C Waller Saad A W Shakir

    Michael Perrio, Patrick Waller, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2007 Mar;16(3)

View Publication

An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.

  • Author

    Lorna Hazell Andrew Boshier Scott Harris Lynda V Wilton Saad A W Shakir

    Lorna Hazell, Andrew Boshier, Scott Harris, Lynda Wilton, Saad Shakir

  • Cite

    BJU Int. 2007 Feb;99(2):387-93

View Publication

Thoughts on signal detection in pharmacovigilance

  • Author

    Saad A W Shakir

    Saad Shakir

  • Cite

    Drug Saf. 2007;30(7):603-6

View Publication

A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.

  • Author

    Michael J Perrio Lynda V Wilton Saad A W Shakir

    Michael Perrio, Lynda Wilton, Saad Shakir

  • Cite

    Drug Safety. 2007;30(8):681-95.

View Publication

Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.

  • Author

    Beverley R Twaites Lynda V Wilton Saad A W Shakir

    Beverley Twaites, Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2007;30(5):419-29

View Publication

Safety profile of rosuvastatin : results of a prescription-event monitoring study of 11 680 patients

  • Author

    Rachna Kasliwal Lynda V Wilton Victoria Cornelius Beate Aurich-Barrera Saad A W Shakir

    Rachna Kasliwal, Lynda Wilton, Victoria Cornelius, Beate Aurich-Barrera, Saad Shakir

  • Cite

    Drug Saf. 2007;30(2):157-70

View Publication

Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance

  • Author

    Michael Perrio Simon Voss Saad A W Shakir

    Michael Perrio, Simon Voss, Saad Shakir

  • Cite

    Drug Saf. 2007;30(4):333-46.

View Publication

Safety profile of orlistat: results of a prescription-event monitoring study

  • Author

    N V Acharya L V Wilton S A W Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Int J Obes (Lond). 2006 Nov;30(11):1645-52

View Publication

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

  • Author

    Josephine Djulus Gideon Koren Thomas R Einarson Lynda Wilton Saad Shakir Orna Diav-Citrin Diane Kennedy Sharon Voyer-Lavigne Marco de Santis Adrienne Einarson

    Josephine Djulus, Gideon Koren, Thomas Einarson, Lynda Wilton, Saad Shakir, Orna Diav-Citrin, Diane Kennedy, Sharon Voyer-Lavigne, Marco de Santis, Adrienne Einarson

  • Cite

    J Clin Psychiatry. 2006 Aug;67(8):1280-4

View Publication

Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

  • Author

    Karyn M Maclennan Andrew Boshier Lynda V Wilton Saad A W Shakir

    Karyn Mackennan, Andrew Boshier, Lynda Wilton, Saad Shakir

  • Cite

    BJU Int. 2006 Jul;98(1):125-31

View Publication

Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study

  • Author

    V Marshall L Wilton S Shakir

    Vanessa Marshall, Lynda Wilton, Saad Shakir

  • Cite

    Acta Diabetol. 2006 May;43(1):6-13

View Publication

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

  • Author

    Deborah Layton Vanessa Marshall Andrew Boshier Peter Friedmann Saad A W Shakir

    Deborah Layton, Vanessa Marshall, Andrew Boshier, Peter Friedmann, Saad Shakir

  • Cite

    Drug Saf. 2006;29(8):687-96

View Publication

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets

  • Author

    Andrea Clarke Jonathan J Deeks Saad A W Shakir

    Andrea Clarke, Jonathan Deeks, Saad Shakir

  • Cite

    Drug Saf. 2006;29(2):175-81.

View Publication

Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England

  • Author

    Beate Aurich-Barrera Lynda Wilton Scott Harris Saad A W Shakir

    Beate Aurich-Barrera, Lynda Wilton, Scott Harris, Saad Shakir

  • Cite

    Drug Saf. 2006;29(2):151-60

View Publication

Under-reporting of adverse drug reactions : a systematic review

  • Author

    Lorna Hazell Saad A W Shakir

    Lorna Hazell, Saad Shakir

  • Cite

    Drug Saf. 2006;29(5):385-96.

View Publication

Bill Inman: drug safety physician and pharmacoepidemiologist

  • Author

    Saad A W Shakir

    Saad Shakir

  • Cite

    Drug Saf. 2006;29(3):187-8

View Publication

Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England

  • Author

    Deborah Layton Lynda Wilton Andrew Boshier Victoria Cornelius Scott Harris Saad A W Shakir

    Deborah Layton, Lynda Wilton, Andrew Boshier, Victoria Cornelius, Scott Harris, Saad Shakir

  • Cite

    Drug Saf. 2006;29(10):897-909

View Publication

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England

  • Author

    Beate Aurich-Barrera Lynda Wilton Scott Harris Saad A W Shakir

    Beate Aurich-Barrera, Lynda Wilton, Scott Harris, Saad Shakir

  • Cite

    Osteoporos Int. 2005 Dec;16(12):1989-98

View Publication

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

  • Author

    Deborah Layton Scott Harris Lynda V Wilton Saad A W Shakir

    Deborah Layton, Scott Harris, Lynda Wilton, Saad Shakir

  • Cite

    J Psychopharmacol. 2005 Sep;19(5):473-82

View Publication

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

  • Author

    Hilary M Pearce Deborah Layton Lynda V Wilton Saad A W Shakir

    Hilary Pearce, Deborah Layton, Lynda Wilton, Saad Shakir

  • Cite

    Br J Clin Pharmacol. 2005 Jul;60(1):98-102

View Publication

The negative effect of red tape on research

  • Author

    A Boshier S A W Shakir P Telfer E Behr T Pakrashi A J Camm

    Andrew Boshier, Saad Shakir, Pauline Telfer, Elijah Behr, Tapesh Pakrashi, John Camm

  • Cite

    Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):373-6

View Publication

Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study

  • Author

    Deborah Layton Andrea Clarke Lynda V Wilton Saad A W Shakir

    Deborah Layton, Andrea Clarke, Lynda Wilton, Saad Shakir

  • Cite

    Osteoporos Int. 2005 May;16(5):490-500

View Publication

The safety and effectiveness of newer antiepileptics: A comparative postmarketing cohort study

  • Author

    Nayan V Acharya Ruth M Pickering Lynda W Wilton Saad A W Shakir

    Nayan Acharya, Ruth Pickering, Lynda Wilton, Saad Shakir

  • Cite

    J Clin Pharmacol. 2005 Apr;45(4):385-93

View Publication

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative stud

  • Author

    Kate McKenna Gideon Koren Maria Tetelbaum Lynda Wilton Saad Shakir Orna Diav-Citrin Andrea Levinson Robert B Zipursky Adrienne Einarson

    Kate McKenna, Gideon Koren, Maria Tetelbaum, Lynda Wilton, Saad Shakir, Orna Diav-Citrin, Andrea Levinson, Robert Zipursky, Adrienne Einarson

  • Cite

    J Clin Psychiatry. 2005 Apr;66(4):444-9

View Publication